Staphylococcus aureus Manganese Transport Protein C Is a Highly Conserved Cell Surface Protein That Elicits Protective Immunity Against S. aureus and Staphylococcus epidermidis-Reference-Cited by-同舟云学术

Staphylococcus aureus Manganese Transport Protein C Is a Highly Conserved Cell Surface Protein That Elicits Protective Immunity Against S. aureus and Staphylococcus epidermidis

Published:2012-04-02 Issue:11 Volume:205 Page:1688-1696
ISSN:1537-6613
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Anderson Annaliesa S.,Scully Ingrid L.,Timofeyeva Yekaterina,Murphy Ellen,McNeil Lisa K.,Mininni Terri,Nuñez Lorna,Carriere Marjolaine,Singer Christine,Dilts Deborah A.,Jansen Kathrin U.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/205/11/1688/18066665/jis272.pdf

Reference28 articles.

1. A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis model;Kuklin;Infect Immun,2006

2. Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant;Josefsson;J Infect Dis,2001

3. Vaccine assembly from surface proteins of Staphylococcus aureus;Stranger-Jones;Proc Natl Acad Sci U S A,2006

4. Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain;Gill;J Bacteriol,2005

5. Role of coagulase-negative staphylococci in human disease;Piette;Vet Microbiol,2009

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The pathogenicity and virulence of the opportunistic pathogen Staphylococcus epidermidis;Virulence;2024-06-13

2. The safety and immunogenicity of a recombinant five-antigen Staphylococcus aureus vaccine among patients undergoing elective surgery for closed fractures: A randomized, double-blind, placebo-controlled, multicenter phase 2 clinical trial;Vaccine;2023-08

3. Efficacy of a 4-Antigen Staphylococcus aureus Vaccine in Spinal Surgery: The STaphylococcus aureus suRgical Inpatient Vaccine Efficacy (STRIVE) Randomized Clinical Trial;Clinical Infectious Diseases;2023-05-01

4. Oral Vaccination with Engineered Probiotic Limosilactobacillus reuteri Has Protective Effects against Localized and Systemic Staphylococcus aureus Infection;Microbiology Spectrum;2023-04-13

5. Immunotherapies for the prevention and treatment of Staphylococcus aureus infections: updates and challenges;Pathogens and Disease;2023